Moody’s affirms ‘Aa2/VMIG 1’ on CHRISTUS Health’s bonds

Moody’s Investors Service has affirmed Irving, Texas-based CHRISTUS Health’s “Aa2/VMIG 1” letter of credit-backed series 2008C-1 bonds, affecting $41.44 million of debt.

Advertisement

Moody’s has evaluated the bonds based on a joint default analysis. Moody’s has determined that the joint probability of default between the bank and the obligor is low, which results in credit risk consistent with a JDA rating of “Aa2.”

More articles on finance:
RCM tip of the day: Educate patients on expected financial responsibility
Altarum: Healthcare spending moderates as job growth surges
What health insurers can learn from ‘Covered California’ and narrow networks

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.